Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Andrew_Slatter
    Member
    • Dec 2010
    • 12

    Alternative index primer

    Has anyone used an alternative custom indexing primer on any of the Illumina sequencing platforms ?
  • suludana
    Member
    • May 2008
    • 61

    #2
    Yes, following the D.Craig paper (Nature Methods, 2008).
    It works fine.

    Comment

    • Andrew_Slatter
      Member
      • Dec 2010
      • 12

      #3
      Yes, I am familiar with this paper. They are using their own index sequences within adaptors - and capturing the index sequence as part of a single read. I am interested in the more recent Illumina chemistry in which paired end reads are performed followed by a separate indexing read. As I understand it, the index read comes from the reverse complement of one of the sequencing primers, thus sequencing 'away' from the genomic sequence and into the index tag. I am interested in whether anyone has experience of using an alternative sequence for the index primer itself (not the index sequences).

      Comment

      • elaney_k
        Member
        • Mar 2008
        • 55

        #4
        Hi Andrew,

        I think you're referring to the Illumina Multiplexing protocol where the index is introduced during the enrichment PCR stage of the protocol. If you contact Illumina techsupport directly they will be able to supply you with the full sequence info for these multiplexing primers. It's easy to spot where the index is and so should be easy enough to get custom-made index primers with as many different combinations as you require. As long as you only change the index part of the sequence and ensure the base composition of the index sequence is as varied as possible (i.e. mix evenly the number of A,C,G and T's for each base of the indexes in the samples that you want to pool) to aid in individual cluster identification everything should work fine. There are definitely groups that have used this method with no problems.

        Elaine

        Comment

        • rjo
          Junior Member
          • Apr 2010
          • 2

          #5
          Hi all,

          Am I correct in thinking that the indexes for the llumina Multiplexing protocol are only 6 bases long? Has anyone tried hacking the protocol to get a longer index sequencing read, therefore allowing multiplexing of more samples?

          Comment

          • henry.wood
            Member
            • Apr 2010
            • 63

            #6
            Originally posted by rjo View Post
            Has anyone tried hacking the protocol to get a longer index sequencing read, therefore allowing multiplexing of more samples?
            More? I've never been brave enough to put more than 25 samples in one lane. Are 4096 per lane not enough for you? I feel suitably humbled.

            Comment

            • rjo
              Junior Member
              • Apr 2010
              • 2

              #7
              No need to be quite so humbled, I wasn't thinking of 4096 different MIDs. Using error correctable MIDs with e.g. a Hamming distance of 2 there are about 215 possible sequences. We regularly multiplex much higher sample numbers than this and analyse on 454.

              Comment

              • HESmith
                Senior Member
                • Oct 2009
                • 512

                #8
                See this post for an alternative approach to validating barcodes.

                Comment

                • NearyJL78
                  Member
                  • Feb 2011
                  • 14

                  #9
                  We've used an approach similar to the Craig paper, with our own 28 adapters. It worked very well, but now we are trying to Illumina multiplexing kits to speed up sample prep. This is not going as smoothly, but apparently you can multiplex up to 48 samples with the kit. Its paired-read - read 1 is the sequence, and read 2 is the adapter.

                  Comment

                  Latest Articles

                  Collapse

                  • SEQadmin2
                    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                    by SEQadmin2


                    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                    The systematic characterization of the human proteome has
                    ...
                    Yesterday, 11:48 AM
                  • SEQadmin2
                    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                    by SEQadmin2



                    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                    ...
                    07-09-2026, 11:10 AM
                  • SEQadmin2
                    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                    by SEQadmin2



                    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                    07-08-2026, 05:17 AM

                  ad_right_rmr

                  Collapse

                  News

                  Collapse

                  Topics Statistics Last Post
                  Started by SEQadmin2, Yesterday, 11:10 AM
                  0 responses
                  9 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-13-2026, 10:26 AM
                  0 responses
                  30 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-09-2026, 10:04 AM
                  0 responses
                  41 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-08-2026, 10:08 AM
                  0 responses
                  26 views
                  0 reactions
                  Last Post SEQadmin2  
                  Working...